|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and due from banks | ||||||||||||||||||||
| Interest-earning deposits with banks | ||||||||||||||||||||
| Loans held for sale | ||||||||||||||||||||
| Investment securities – available-for-sale | ||||||||||||||||||||
| Investment securities – held-to-maturity | ||||||||||||||||||||
| Loans | ||||||||||||||||||||
| Allowance for loan and lease losses | ||||||||||||||||||||
| Net loans | ||||||||||||||||||||
| Equity investments | ||||||||||||||||||||
| Mortgage servicing rights | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Deposits | ||||||||||||||||||||
| Noninterest-bearing | ||||||||||||||||||||
| Interest-bearing | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| Borrowed funds | ||||||||||||||||||||
| Federal Home Loan Bank advances | ||||||||||||||||||||
| Senior debt | ||||||||||||||||||||
| Subordinated debt | ||||||||||||||||||||
| Other | ||||||||||||||||||||
| Total borrowed funds | ||||||||||||||||||||
| Total borrowed funds | ||||||||||||||||||||
| Allowance for unfunded lending related commitments | ||||||||||||||||||||
| Accrued expenses and other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Equity | ||||||||||||||||||||
| Preferred stock | ||||||||||||||||||||
| Common Stock, Shares, Issued | ||||||||||||||||||||
| Common stock ($5 par value, Authorized 800,000,000 shares, issued 557,291,838 and 543,497,966 shares) | ||||||||||||||||||||
| Capital surplus | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||||
| Common stock held in treasury at cost: 145,068,954 and $145,087,054 shares | ||||||||||||||||||||
| Common stock held in treasury at cost: 157,826,113 and 153,084,091 shares | ||||||||||||||||||||
| Total shareholders’ equity | ||||||||||||||||||||
| Noncontrolling interests | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities and equity | ||||||||||||||||||||
Loading...
